BIOMAT Database Logo BIOMAT Database Logo

Effect of non-invasive prenatal testing as a contingent approach on the indications for invasive prenatal diagnosis and prenatal detection rate of Down's syndrome. 2016

K O Kou, and C F Poon, and S L Kwok, and K Yk Chan, and M Hy Tang, and A Sy Kan, and K Y Leung
Department of Obstetrics and Gynaecology, Queen Elizabeth Hospital, Jordan, Hong Kong.

BACKGROUND In Hong Kong, universal combined first-trimester screening for Down's syndrome was started as a 'free service' in July 2010. Non-invasive prenatal testing was available as a self-financed item in August 2011. This study aimed to determine whether the introduction of non-invasive prenatal testing as a contingent approach influenced the indications for invasive prenatal diagnosis and the consequent prenatal detection of Down's syndrome. METHODS This historical cohort study was conducted at the Prenatal Diagnosis Clinic of Queen Elizabeth Hospital in Hong Kong. We compared the indications for invasive prenatal diagnosis and prenatal detection of Down's syndrome in singleton pregnancies 1 year before and 2 years following the availability of non-invasive prenatal testing as a contingent test after a positive aneuploidy test. All pregnant women who attended our hospital for counselling about universal Down's syndrome screening between August 2010 and July 2013 were recruited. RESULTS A total of 16 098 women were counselled. After the introduction of non-invasive prenatal testing, the invasive prenatal diagnosis rate for a positive aneuploidy screening reduced from 77.7% in 2010-11 to 68.8% in 2012-13. The new combined conventional plus non-invasive prenatal testing strategy was associated with a lower false-positive rate (6.9% in 2010-11 vs 5.2% in 2011-12 and 4.9% in 2012-13). There was no significant increase in invasive prenatal diagnosis for structural anomalies over the years. There was no significant trend in the overall prenatal detection rate of Down's syndrome (100% 1 year before vs 89.1% 2 years after introduction of non-invasive prenatal testing). Four (2.6%) of 156 women who underwent non-invasive prenatal testing for a screen-positive result had a high-risk result for trisomy 21, which was subsequently confirmed by invasive prenatal diagnosis. There were no false-negative cases. CONCLUSIONS The introduction of non-invasive prenatal testing as a contingent approach reduced the invasive prenatal diagnosis rate for a positive aneuploidy screening without affecting the invasive prenatal diagnosis rate for structural anomalies or the overall detection rate of fetal Down's syndrome.

UI MeSH Term Description Entries
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D008423 Maternal Age The age of the mother in PREGNANCY. Age, Maternal,Ages, Maternal,Maternal Ages
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011261 Pregnancy Trimester, First The beginning third of a human PREGNANCY, from the first day of the last normal menstrual period (MENSTRUATION) through the completion of 14 weeks (98 days) of gestation. Early Placental Phase,Pregnancy, First Trimester,Trimester, First,Early Placental Phases,First Pregnancy Trimester,First Pregnancy Trimesters,First Trimester,First Trimester Pregnancies,First Trimester Pregnancy,First Trimesters,Phase, Early Placental,Phases, Early Placental,Placental Phase, Early,Placental Phases, Early,Pregnancies, First Trimester,Pregnancy Trimesters, First,Trimesters, First
D011296 Prenatal Diagnosis Determination of the nature of a pathological condition or disease in the postimplantation EMBRYO; FETUS; or pregnant female before birth. Diagnosis, Prenatal,Fetal Diagnosis,Fetal Imaging,Fetal Screening,Intrauterine Diagnosis,Antenatal Diagnosis,Antenatal Screening,Diagnosis, Antenatal,Diagnosis, Intrauterine,Prenatal Screening,Antenatal Diagnoses,Antenatal Screenings,Diagnosis, Fetal,Fetal Diagnoses,Fetal Imagings,Fetal Screenings,Imaging, Fetal,Intrauterine Diagnoses,Prenatal Diagnoses,Prenatal Screenings,Screening, Antenatal,Screening, Fetal,Screening, Prenatal
D004314 Down Syndrome A chromosome disorder associated either with an extra CHROMOSOME 21 or an effective TRISOMY for chromosome 21. Clinical manifestations include HYPOTONIA, short stature, BRACHYCEPHALY, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, single transverse palmar crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213) Mongolism,Trisomy 21,47,XX,+21,47,XY,+21,Down Syndrome, Partial Trisomy 21,Down's Syndrome,Partial Trisomy 21 Down Syndrome,Trisomy 21, Meiotic Nondisjunction,Trisomy 21, Mitotic Nondisjunction,Trisomy G,Downs Syndrome,Syndrome, Down,Syndrome, Down's
D005189 False Positive Reactions Positive test results in subjects who do not possess the attribute for which the test is conducted. The labeling of healthy persons as diseased when screening in the detection of disease. (Last, A Dictionary of Epidemiology, 2d ed) False Positive Reaction,Positive Reaction, False,Positive Reactions, False,Reaction, False Positive,Reactions, False Positive
D005260 Female Females
D006723 Hong Kong The former British crown colony located off the southeast coast of China, comprised of Hong Kong Island, Kowloon Peninsula, and New Territories. The three sites were ceded to the British by the Chinese respectively in 1841, 1860, and 1898. Hong Kong reverted to China in July 1997. The name represents the Cantonese pronunciation of the Chinese xianggang, fragrant port, from xiang, perfume and gang, port or harbor, with reference to its currents sweetened by fresh water from a river west of it. Kowloon,New Territories,Hongkong
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

K O Kou, and C F Poon, and S L Kwok, and K Yk Chan, and M Hy Tang, and A Sy Kan, and K Y Leung
Non-invasive prenatal diagnosis of Down's syndrome.
June 2007, Lancet (London, England),
K O Kou, and C F Poon, and S L Kwok, and K Yk Chan, and M Hy Tang, and A Sy Kan, and K Y Leung
Non-invasive prenatal diagnosis of Down's syndrome.
June 2007, Lancet (London, England),
K O Kou, and C F Poon, and S L Kwok, and K Yk Chan, and M Hy Tang, and A Sy Kan, and K Y Leung
Non-invasive prenatal diagnosis of Down's syndrome.
March 2001, Lancet (London, England),
K O Kou, and C F Poon, and S L Kwok, and K Yk Chan, and M Hy Tang, and A Sy Kan, and K Y Leung
Non-invasive prenatal diagnosis of Down's syndrome.
June 2007, Lancet (London, England),
K O Kou, and C F Poon, and S L Kwok, and K Yk Chan, and M Hy Tang, and A Sy Kan, and K Y Leung
Non-invasive prenatal testing for everybody or contingent screening?
April 2023, Prenatal diagnosis,
K O Kou, and C F Poon, and S L Kwok, and K Yk Chan, and M Hy Tang, and A Sy Kan, and K Y Leung
Non-invasive prenatal testing for Down's syndrome: pregnant women's views and likely uptake.
January 2013, Public health genomics,
K O Kou, and C F Poon, and S L Kwok, and K Yk Chan, and M Hy Tang, and A Sy Kan, and K Y Leung
Will the introduction of non-invasive prenatal testing for Down's syndrome undermine informed choice?
October 2015, Health expectations : an international journal of public participation in health care and health policy,
K O Kou, and C F Poon, and S L Kwok, and K Yk Chan, and M Hy Tang, and A Sy Kan, and K Y Leung
Extending non-invasive prenatal testing to non-invasive prenatal diagnosis.
January 2019, Archives of disease in childhood. Fetal and neonatal edition,
K O Kou, and C F Poon, and S L Kwok, and K Yk Chan, and M Hy Tang, and A Sy Kan, and K Y Leung
[Clinical effect of expanded non-invasive prenatal testing for serological screening of fetuses with high-risk for Down's syndrome].
October 2021, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics,
K O Kou, and C F Poon, and S L Kwok, and K Yk Chan, and M Hy Tang, and A Sy Kan, and K Y Leung
Non-invasive prenatal testing for Down syndrome.
February 2014, Seminars in fetal & neonatal medicine,
Copied contents to your clipboard!